购物车
全部删除
您的购物车当前为空
KRAS-IN-43 (Compound 9) 是广谱KRAS抑制剂,其IC50值为KRASG12V 0.15 μM、KRASG12C 0.14 μM和野生型KRAS 0.47 μM。该化合物能够破坏KRAS与cRAF的相互作用,并抑制ERK的磷酸化。KRAS-IN-43 有望用于KRAS突变相关癌症(如胰腺癌、结直肠癌和肺癌)的研究。
KRAS-IN-43 (Compound 9) 是广谱KRAS抑制剂,其IC50值为KRASG12V 0.15 μM、KRASG12C 0.14 μM和野生型KRAS 0.47 μM。该化合物能够破坏KRAS与cRAF的相互作用,并抑制ERK的磷酸化。KRAS-IN-43 有望用于KRAS突变相关癌症(如胰腺癌、结直肠癌和肺癌)的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
KRAS-IN-43 相关产品
| 产品描述 | KRAS-IN-43 (Compound 9) is a broad-spectrum KRAS inhibitor with IC50 values of 0.15 μM for KRASG12V, 0.14 μM for KRASG12C, and 0.47 μM for wild-type KRAS. It disrupts the interaction between KRAS and cRAF and suppresses ERK phosphorylation. KRAS-IN-43 shows potential for research in KRAS mutation-associated cancers, including pancreatic, colorectal, and lung cancers. |
| 靶点活性 | KRas (G12V):0.15 μM |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容